Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
October 01, 2013 at 06:20 AM EDT
Amgen (NASDAQ: AMGN ) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of common stock of Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX ) for $125 per share in cash. As announced on Aug. 25, the purchase price is $9.7
